RxDoctor Payments Data

Kristi Kerner, MD

Family Medicine · Greenwood, INNPI 1992787964

Payments from drug & device makers

$3,819in general payments, 2019–2025

Across 267 payments — averaging $14.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$978
  • Amgen$602
  • Novo Nordisk$366
  • Boehringer Ingelheim$234
  • GSK$185
  • Pfizer$152
  • plus $1K from 34 others

What the payments were for

  • Food & beverage$3,819100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,819 in reported general payments places this provider in the 80th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$189,003
Medicare patients
425
Services billed
8,529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide139$181,156
EliquisApixaban132$133,063
JardianceEmpagliflozin113$120,643
Trelegy ElliptaFluticasone/Umeclidin/Vilanter83$106,751
MounjaroTirzepatide53$61,933
JanuviaSitagliptin Phosphate37$54,637
MyrbetriqMirabegron58$46,455
FarxigaDapagliflozin Propanediol34$45,193
XareltoRivaroxaban28$40,585
Breo ElliptaFluticasone/Vilanterol58$34,623
LinzessLinaclotide35$33,515
Spiriva RespimatTiotropium Bromide24$21,656
Repatha SureclickEvolocumab15$16,697
Omeprazole564$8,391
Gabapentin364$8,366

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$366$181,156139 claims
Boehringer IngelheimJardiance, Spiriva Respimat$234$142,299137 claims
GSKTrelegy Ellipta, Breo Ellipta$185$141,375141 claims
PfizerEliquis$152$133,063132 claims
Lilly USA, LLCMounjaro$145$61,93353 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$24$61,00271 claims
MerckJanuvia$40$54,63737 claims
Astellas Pharma US IncMyrbetriq$68$46,45558 claims
Johnson & JohnsonXarelto$24$40,58528 claims
AbbVieLinzess, Synthroid$978$40,180125 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$6,232797 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Greenwood

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →